Acebrophylline-induced angioedema
- PMID: 25878387
- PMCID: PMC4386136
- DOI: 10.4103/0253-7613.153435
Acebrophylline-induced angioedema
Abstract
A 53-year-old woman visited her physician complaining of acute breathlessness and productive cough. Her medications included budesonide and formoterol for asthma, fixed-dose combination aspirin 150 mg + clopidogrel 75 mg + atorvastatin 20 mg for ischemic heart disease. History revealed that she had allergic rhinitis and was hypersensitive to penicillins. The patient was prescribed acebrophylline (ABP). Six hours after ABP therapy she presented with generalized urticarial lesions, swelling of hands, feet, lips and face, suggestive of angioedema. ABP was stopped immediately, and the patient was treated symptomatically. This case was categorized as probable as per standard causality assessment scale.
Keywords: Allergic; Naranjo's scale; de-challenge; urticarial lesions.
Conflict of interest statement
References
-
- Inomata N. Recent advances in drug-induced angioedema. Allergol Int. 2012;61:545–57. - PubMed
-
- Salih I, Thomas S. Causes and management of drug-induced angioedema. Prescriber. 2006;17:14–8.
-
- Pozzi E. Acebrophylline: An airway mucoregulator and anti-inflammatory agent. Monaldi Arch Chest Dis. 2007;67:106–15. - PubMed
-
- Goldrub N, Soares VR, Hamoui A, Zavattini G, Poli A. Therapeutic activity and tolerability profile of acebrophylline. Adv Ther. 1992;9:107–15.
-
- Cocco G, Zavattini G, Padovano A. Acebrofillina: Studio della morfologia della curva nel broncospasmo da metacolina. Giorn It Mal Tor. 1992;1:103–6.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources